Clinical Trials DEA Decriminalization Marijuana 
SpeedWeed
SEPTEMBER 4, 2021
The DEA published a new document in the Federal Register on September 2 requesting an increase in production for certain Schedule I and Schedule II substances so that it can initiate more research studies. . DEA firmly believes in supporting regulated research of schedule I controlled substances. “DEA
Canna Law Blog
NOVEMBER 27, 2021
DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. So according to the DEA, its abuse potential is high and it has no medical use. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NewsMunchies
NOVEMBER 12, 2021
In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. Additional clinical trials underway in the U.S. Can I get in trouble for using psilocybin?
Cannabis Law Report
MAY 29, 2022
7] And cities around the country are beginning to decriminalize some psychedelics, with advocates for decriminalization citing the potential medical benefits. In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., Clinical Trials and Human Subject Protections.
Cannabis Law Report
MAY 31, 2022
The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. These therapists will likely benefit from further decriminalization measures and may be able to transition to state-regulated systems as these go live.
Cannabis Law Report
MARCH 2, 2020
In lockstep with the FDA’s more open-minded approach toward psychedelic medicine, Denver, Oakland, and Santa Cruz all decided to decriminalize magic mushrooms. Any approved medicines will have to be rescheduled by the Drug Enforcement Administration (DEA). Hundreds of other U.S. The dawn of a new era in psychedelic medicine.
Canna Law Blog
NOVEMBER 6, 2021
The following year, President Richard Nixon declared drug abuse public enemy number one, and in 1973, he formed the Drug Enforcement Administration (DEA). Instead, qualifying evidence may come from adequate and well-controlled clinical trials. Phase I trials should be sufficient, and many have been completed using psilocybin.
Expert insights. Personalized for you.
52 
Let's personalize your content